Posted in | News | Quantum Computing

Quantum Machine Learning Boosts Alzheimer's Detection

In an article recently published in the journal Scientific Reports, researchers proposed a quantum machine learning (QML) and deep ensemble learning-based approach for the detection of Alzheimer's disease (AD).

Quantum Machine Learning Boosts Alzheimer
Comparison of individual models using performance metrics. Image Credit: https://www.nature.com/articles/s41598-024-61452-1

Background

Alzheimer's disease is one of the most chronic neurodegenerative disorders threatening global public health. This degenerative brain disorder diminishes critical mental abilities like memory, and patients suffering from AD face diverse challenges, including mobility issues, memory loss, behavioral defects, and cognitive impairment.

Thus, early diagnosis is crucial for timely intervention and medication to improve the quality of life of affected individuals. Structural magnetic resonance imaging (MRI), an asymptomatic diagnostic method, is recognized as a common imaging biomarker in categorizing and identifying AD stages as non-demented, very mild demented, moderate demented, and mild demented.

To this end, deep learning (DL) techniques have displayed substantial improvements in disease detection, classification, and detection tasks. Ensemble learning can further boost the performance of these DL models. Additionally, QML, which is the intersection of quantum computing and classical ML, has also gained significant attention from the scientific community due to its promising speed and scalability, representation power, and flexibility.

Quantum computing provides a more efficient model for various disease classification tasks compared to classical ML approaches, with many studies demonstrating the advantages of QML algorithms over conventional ML algorithms for several applications like healthcare. However, the full quantum computing potential has not been applied to AD classification tasks.

The Study

In this work, researchers proposed an ensemble DL model based on QML classifiers for classifying AD. The proposed model can detect the AD stages from a brain MRI using an ensemble of customized versions of VGG16-ResNet50 DL models as feature extraction and then applying QML algorithms for classification.

The objective of the study was to develop an efficient model by integrating different source data to come up with a better outcome prediction to address the challenge of AD classification. The Alzheimer's Disease Neuroimaging Initiative II (ADNI2) and Alzheimer's Disease Neuroimaging Initiative I (ADNI1) MRI datasets, obtained from Kaggle, were combined for the Alzheimer's disease classification.

Key AD features extracted from the merged images/ADNI MRI image data using the customized version of the ensemble DL algorithm/VGG16 and ResNet50 models were initially combined and fed to the QML classifier.

The QML classifier/quantum support vector machine (QSVM) then classified them as very mild demented, moderate demented, mild demented, and non-demented. Thus, the proposed approach can make decisions in a more varied, thorough, and dependable manner.

Researchers evaluated the proposed model's performance using multiple metrics, including recall, precision, F1-score, the area under the curve, and accuracy, and investigated the effect of QML to effectively improve the model's computational efficiency. They also investigated the effectiveness of the model against other techniques, including convolutional neural networks (CNN), Inception-ResNet-V2, VGG16, AlexNet, and Random Forest and Adaptive Boosting classifiers.

Additionally, the researchers evaluated the performance of ensemble learning methods with the QSVM and classical SVM classifiers. They utilized a five-qubit quantum simulator/hardware and the QSVM model from the Qiskit library. The QSVM model was optimized by adding hyperparameters.

Importance of this Work

The results of individual DL models showed that ResNet had a poor performance based on F1 score and recall, while VGGNet realized outstanding results along with ensemble models. The area under the curve fared better compared to other metrics, with VGGNet, ResNet, and the ensemble model achieving 97.59, 93.70, and 98.84 scores, respectively.

Researchers examined the effects of the SVM-based DL models on the AD dataset. Results showed that the VGGNet+SVM model attained an 85 % F1 score, 85.30 % recall, 85.24 % accuracy, 89.18 % area-under-the-curve score, and 85.00 % precision, while the ResNet+SVM model realized 82.24 % accuracy, 84.73 F1-score, and 85.43 recall. The proposed ensemble (VGGNet+ResNet) with the classical SVM model realized the highest 86.78 % accuracy and 90.53 % area under the curve score.

The results of DL models with QSVM also displayed that the proposed ensemble model+QSVM had a better performance compared to VGGNet+QSVM and ResNet+QSVM, with the ensemble model+QSVM achieving the highest accuracy of 99.89, precision of 99.25, and area under the curve score of 99.99 on the merged ADNI dataset.

These results validated that the proposed ensemble model with SVM and QSVM outperforms DL with classical SVM and DL with QSVM. Moreover, the proposed model also outperformed other techniques for AD detection by achieving the highest accuracy of 99.89 on the merged ADNI1+ADNI2 dataset, surpassing the previous best accuracy of 99.68 achieved by CNN on the OASIS dataset.

To summarize, the proposed approach provides an effective solution to support AD primary care, specifically when the MRI scan is blurred, which makes it difficult for experts to suggest the disease properly.

Journal Reference

Jenber Belay, A., Walle, Y. M., Haile, M. B. (2024). Deep Ensemble learning and quantum machine learning approach for Alzheimer’s disease detection. Scientific Reports, 14(1), 1-10. https://doi.org/10.1038/s41598-024-61452-1, https://www.nature.com/articles/s41598-024-61452-1

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Samudrapom Dam

Written by

Samudrapom Dam

Samudrapom Dam is a freelance scientific and business writer based in Kolkata, India. He has been writing articles related to business and scientific topics for more than one and a half years. He has extensive experience in writing about advanced technologies, information technology, machinery, metals and metal products, clean technologies, finance and banking, automotive, household products, and the aerospace industry. He is passionate about the latest developments in advanced technologies, the ways these developments can be implemented in a real-world situation, and how these developments can positively impact common people.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dam, Samudrapom. (2024, June 26). Quantum Machine Learning Boosts Alzheimer's Detection. AZoQuantum. Retrieved on July 02, 2024 from https://www.azoquantum.com/News.aspx?newsID=10346.

  • MLA

    Dam, Samudrapom. "Quantum Machine Learning Boosts Alzheimer's Detection". AZoQuantum. 02 July 2024. <https://www.azoquantum.com/News.aspx?newsID=10346>.

  • Chicago

    Dam, Samudrapom. "Quantum Machine Learning Boosts Alzheimer's Detection". AZoQuantum. https://www.azoquantum.com/News.aspx?newsID=10346. (accessed July 02, 2024).

  • Harvard

    Dam, Samudrapom. 2024. Quantum Machine Learning Boosts Alzheimer's Detection. AZoQuantum, viewed 02 July 2024, https://www.azoquantum.com/News.aspx?newsID=10346.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.